Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-19
1998-03-10
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142372, 514315, 514318, 514330, 544129, 546153, 546192, 546193, 546194, 546146, C07D21700, C07D21100, A61K 3147, A61K 31445
Patent
active
057261849
ABSTRACT:
The present invention relates to compounds that can maintain, increase, or restore sensitivity of cells to therapeutic or prophylactic agents. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well-suited for treatment of multi-drug resistant cells, for prevention of the development of multi-drug resistance, and for use in multi-drug resistant cancer.
REFERENCES:
patent: 5192773 (1993-03-01), Armistead et al.
Davis Zinna Northington
Haley, Jr. James F.
Marks Andrew S.
Vertex Pharmaceuticals Incorporated
LandOfFree
Tetralin compounds with improved MDR activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetralin compounds with improved MDR activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetralin compounds with improved MDR activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-139807